Filing Details

Accession Number:
0001209191-13-039706
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-07 16:34:01
Reporting Period:
2013-08-05
Filing Date:
2013-08-07
Accepted Time:
2013-08-07 16:34:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099219 Metlife Inc MET Life Insurance (6311) 134075851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273281 J William Wheeler 200 Park Avenue
New York NY 10166
President Of The Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-05 40,000 $35.26 270,867 No 4 M Direct
Common Stock Disposition 2013-08-05 40,000 $50.92 230,867 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2013-08-05 40,000 $0.00 40,000 $35.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,665 Indirect By GRAT
Common Stock 10 Indirect By the MetLife Policyholder Trust
Footnotes
  1. On August 5, 2013, 3,785 shares were distributed in accordance with the terms of a Granter Retained Annuity Trust ("GRAT"), and as a result are now directly held by the Reporting Person.
  2. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  3. These shares were sold in multiple transactions at prices ranging from $50.91 to $50.97, inclusive.
  4. These shares were previously reported as directly beneficially owned but were contributed to the GRAT.
  5. Shares held in trust under the MetLife Policyholder Trust established to hold shares of Common Stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.
  6. The option became exercisable in three equal installments on February 17, 2005, 2006 and 2007.